Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Clinical trial NCT02223819 · COMPLETED
Trial details
- NCT number
- NCT02223819
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2019-07-03
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.